The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer

Published:2014-07-08 Issue:5 Volume:111 Page:837-842
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Exner R,Bago-Horvath Z,Bartsch R,Mittlboeck M,Retèl V P,Fitzal F,Rudas M,Singer C,Pfeiler G,Gnant M,Jakesz R,Dubsky P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2014339.pdf

Reference23 articles.

1. Albain KS, Paik S, Van’t Veer L (2009) Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays. Breast 18 (Suppl 3): S141–S145.

2. Azim HA Jr, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, Andre F, Loi S, Swanton C (2013) Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. Ann Oncol 24: 647–654.

3. Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer CF, Kemmerling R, Greil R, Jelen A, Bohm G, Jasarevic Z, Haid A, Gruber C, Postlberger S, Filipits M, Gnant M (2011) Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer. Clin Cancer Res 17: 7828–7834.

4. Bueno-De-Mesquita JM, Linn SC, Keijzer R, Wesseling J, Nuyten DS, Van Krimpen C, Meijers C, De Graaf PW, Bos MM, Hart AA, Rutgers EJ, Peterse JL, Halfwerk H, De Groot R, Pronk A, Floore AN, Glas AM, Van't Veer LJ, Van De Vijver MJ (2009) Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat 117: 483–495.

5. Buyse M, Loi S, Van't Veer L, Viale G, Delorenzi M, Glas AM, D'assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98: 1183–1192.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker and multigene assay testing in ER positive, HER-2 negative breast carcinomas: An international guidelines-based approach;Human Pathology Reports;2021-11

2. The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa;The Breast;2021-10

3. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy;npj Breast Cancer;2021-05-05

4. De novo assembly and annotation of a highly contiguous reference genome of the fathead minnow (Pimephales promelas) reveals an AT-rich repetitive genome with compact gene structure;2021-02-25

5. Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers;Current Drug Targets;2020-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3